Integrating Allogeneic NK Cells in High-risk Advanced Stage III-IV Nasopharyngeal Cancer Patients

Clinical trial NCT07247201 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07247201
Sponsor: Singapore General Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Nasopharyngeal Carcinoma (NPC)Minimal Residual Disease Recurrent Nasopharyngeal Carcinoma Maximum Tolerated Dose

Start date: 2026-04-01
Primary completion: 2026-04-01
Enrollment: 31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.